BioNTech
BNTX
95.25
-0.48
-0.50%
BioNTech
US · BNTX
#801 by market cap
Listed 2019
95.25
-0.48
-0.50%
Live - 5344 symbols - heartbeat 248s ago
· 2026-10-08 08:21
Pre-market
94.52
-0.77%
After-hours
96.00
+0.79%
Overnight
95.00
-0.26%
- Market cap
- 23.93B
- P/E (TTM)i
- -12.68
- P/Bi
- 1.20
- EPSi
- -5.26
- Div yieldi
- 0.00%
- 52W posi
- 35%
Reader sentiment
Are you bullish or bearish on BNTX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 60.66% -0.03pp
- Institutions
- 407 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
VC/PE Fund41.77%
Individual/Insider16.15%
Mutual Fund13.92%
Hedge Fund2.56%
Private Company0.98%
Public Company0.93%
Sovereign Wealth Fund0.29%
Government Pension Fund0.17%
Other23.20%
Top holders as of 2026-03-31
AT Impf GmbH
40.49% · 101.70M sh
Ugur Sahin
15.75% · 39.56M sh
FMR
3.01% · 7.56M sh
PRIMECAP Management Company
1.50% · 3.77M sh
Dodge & Cox
1.46% · 3.68M sh
T. Rowe Price Group, Inc.
0.89% · 2.23M sh
Flossbach von Storch SE
0.89% · 2.23M sh
BlackRock
0.74% · 1.85M sh
Temasek Holdings
0.60% · 1.51M sh
BNP Paribas Financial Markets SNC
0.53% · 1.32M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 10 buys · 19 sells
| Name | Role | Stake |
|---|---|---|
| AT Impf GmbH | -- | 40.49% |
| Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | 15.75% |
| Sierk Pötting | MD, COO & Member of Management Board | 0.22% |
| Helmut Jeggle | Independent Supervisory Board Chairman | 0.13% |
| Ozlem Tureci | Co-Founder, Chief Medical Officer & Member of Management Board | 0.05% |
| James Timothy Ryan | Chief Legal Officer & Member of the Management Board | 0.00% |
| Rudolf Staudigl | Supervisory Board Member | 0.00% |
| Anja Morawietz | Supervisory Board Member | 0.00% |
| Ryan Richardson | Chief Strategy Officer, MD & Member of Management Board | -- |
| Salvia GmbH | -- | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Automatic Disposition | -34,000 | $96.72–97.46 |
| 2026-09-29 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Automatic Disposition | -66,000 | $98.12–98.26 |
| 2026-09-27 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Automatic Disposition | -61,000 | $98.47–98.69 |
| 2026-09-23 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Automatic Disposition | -69,000 | $98.99–99.40 |
| 2026-09-21 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Automatic Disposition | -79,000 | $97.81–100.72 |
| 2026-09-17 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Automatic Disposition | -64,000 | $96.22–98.60 |
| 2026-09-15 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Automatic Disposition | -49,000 | $96.09–96.49 |
| 2026-09-13 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Private Disposition | -86,000 | $96.93–99.45 |
| 2026-09-09 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Automatic Disposition | -20,500 | $96.31 |
| 2026-09-08 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Automatic Disposition | -73,000 | $97.78–99.20 |
| 2026-09-03 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Automatic Disposition | -76,500 | $102.85–103.52 |
| 2026-09-02 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Intent to Sell (Form 144) | -858,209 | $103.81 |
| 2026-05-12 | Ugur Sahin | Co-Founder, CEO & Chair of the Management Board | Intent to Sell (Form 144) | -858,209 | $93.66 |
| 2026-05-11 | Sierk Pötting | MD, COO & Member of Management Board | Other Derivative Acquisition | +10,069 | -- |
| 2026-05-11 | Sierk Pötting | MD, COO & Member of Management Board | Other Derivative Acquisition | +12,586 | -- |
| 2026-05-11 | James Timothy Ryan | Chief Legal Officer & Member of the Management Board | Other Derivative Acquisition | +10,069 | -- |
| 2026-05-11 | James Timothy Ryan | Chief Legal Officer & Member of the Management Board | Other Derivative Acquisition | +12,586 | -- |
| 2026-05-11 | Annemarie Hanekamp | Chief Commercial Officer | Other Derivative Acquisition | +10,069 | -- |
| 2026-05-11 | Annemarie Hanekamp | Chief Commercial Officer | Other Derivative Acquisition | +12,586 | -- |
| 2026-05-11 | Ramon Zapata-Gomez | CFO & Member of Management Board | Other Derivative Acquisition | +15,103 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:21:22 · For reference only, not investment advice and not tailored to your situation.